"Receptors, Interleukin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface proteins that bind interleukins and trigger intracellular changes influencing the behavior of cells.
| Descriptor ID |
D018123
|
| MeSH Number(s) |
D12.776.543.750.705.852.420
|
| Concept/Terms |
Receptors, Interleukin- Receptors, Interleukin
- Interleukin Receptors
- Interleukin Receptor
- Receptor, Interleukin
- Receptors, Interleukins
- Interleukins Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin".
- Receptors, Interleukin
- Receptors, Interleukin-1
- Receptors, Interleukin-10
- Receptors, Interleukin-11
- Receptors, Interleukin-12
- Receptors, Interleukin-13
- Receptors, Interleukin-15
- Receptors, Interleukin-16
- Receptors, Interleukin-17
- Receptors, Interleukin-18
- Receptors, Interleukin-2
- Receptors, Interleukin-21
- Receptors, Interleukin-3
- Receptors, Interleukin-4
- Receptors, Interleukin-5
- Receptors, Interleukin-6
- Receptors, Interleukin-7
- Receptors, Interleukin-8
- Receptors, Interleukin-9
This graph shows the total number of publications written about "Receptors, Interleukin" by people in this website by year, and whether "Receptors, Interleukin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 5 | 1 | 6 |
| 2018 | 2 | 6 | 8 |
| 2019 | 3 | 2 | 5 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Interleukin" by people in Profiles.
-
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. Expert Opin Biol Ther. 2021 02; 21(2):271-277.
-
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments. Fundam Clin Pharmacol. 2020 Oct; 34(5):530-547.
-
Evidence that tissue resident human enthesis ?dT-cells can produce IL-17A independently of IL-23R transcript expression. Ann Rheum Dis. 2019 11; 78(11):1559-1565.
-
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis. Eur Respir J. 2019 07; 54(1).
-
Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease. JCI Insight. 2019 04 23; 5.
-
Histone Acetylation of Immune Regulatory Genes in Human Placenta in Association with Maternal Intake of Olive Oil and Fish Consumption. Int J Mol Sci. 2019 03 01; 20(5).
-
Increased interleukin-23 receptor (IL-23R) expression is associated with disease severity in acute-on-chronic liver failure. Liver Int. 2019 06; 39(6):1062-1070.
-
IL-23 in inflammatory bowel diseases and colon cancer. Cytokine Growth Factor Rev. 2019 02; 45:1-8.
-
Mechanisms of molecular resistance and predictors of response to biological therapy in inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2018 11; 3(11):790-802.
-
Novel systemic drugs in treatment of atopic dermatitis: results from phase II and phase III studies published in 2017/2018. Curr Opin Allergy Clin Immunol. 2018 10; 18(5):432-437.